PTC Therapeutics Inc. (PTCT) announced Tuesday morning that it has received a Refuse to File letter from the FDA regarding its New Drug Application for Translarna. The letter stated that the application was not sufficiently complete to permit a substantive review.
from RTT - Before the Bell http://ift.tt/1oGPlLN
via IFTTT
No comments:
Post a Comment